Rights and permissions
About this article
Cite this article
Deaths prevented with MCV4 vax outweigh Guillain-Barré risk. Pharmacoecon. Outcomes News 596, 4 (2010). https://doi.org/10.2165/00151234-201005960-00012
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201005960-00012